Tvardi Therapeutics, Inc. (TVRD)
2.66
-0.04
(-1.48%)
USD |
NASDAQ |
Jun 11, 13:41
Tvardi Therapeutics EPS Diluted (TTM) : -3.095 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -3.095 |
| December 31, 2025 | -6.089 |
| September 30, 2025 | -10.25 |
| June 30, 2025 | -86.74 |
| March 31, 2025 | -118.24 |
| December 31, 2024 | -134.77 |
| September 30, 2024 | -151.20 |
| June 30, 2024 | -92.73 |
| March 31, 2024 | -81.20 |
| December 31, 2023 | -78.78 |
| September 30, 2023 | -77.73 |
| June 30, 2023 | -74.65 |
| March 31, 2023 | -56.49 |
| December 31, 2022 | -57.34 |
| September 30, 2022 | -59.80 |
| June 30, 2022 | -45.00 |
| March 31, 2022 | -64.29 |
| December 31, 2021 | -62.42 |
| September 30, 2021 | 17.51 |
| June 30, 2021 | 5.565 |
| March 31, 2021 | 8.392 |
| December 31, 2020 | 2.913 |
| September 30, 2020 | -76.30 |
| June 30, 2020 | -90.18 |
| March 31, 2020 | -91.66 |
| Date | Value |
|---|---|
| December 31, 2019 | -89.36 |
| September 30, 2019 | -86.15 |
| June 30, 2019 | -77.96 |
| March 31, 2019 | -75.92 |
| December 31, 2018 | -74.40 |
| September 30, 2018 | -71.03 |
| June 30, 2018 | -66.35 |
| March 31, 2018 | -58.07 |
| December 31, 2017 | -68.76 |
| September 30, 2017 | -82.44 |
| June 30, 2017 | -83.88 |
| March 31, 2017 | -90.72 |
| December 31, 2016 | -75.60 |
| September 30, 2016 | -59.03 |
| June 30, 2016 | -50.75 |
| March 31, 2016 | -42.47 |
| December 31, 2015 | -35.99 |
| September 30, 2015 | -29.88 |
| June 30, 2015 | -33.48 |
| March 31, 2015 | -30.24 |
| December 31, 2014 | -30.60 |
| September 30, 2014 | -46.95 |
| June 30, 2014 | -39.68 |
| March 31, 2014 | -22.04 |
| December 31, 2013 | -31.40 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Nektar Therapeutics | -8.420 |
| Assertio Holdings, Inc. | -5.733 |
| Eli Lilly & Co. | 27.78 |
| ANI Pharmaceuticals, Inc. | 3.942 |
| Corcept Therapeutics, Inc. | 0.35 |